Hieronder staat een overzicht van de meest relevante klinische publicaties uit Nederland en eventueel ook in het buitenland, waar tenminste 1 DUPROTON protonentherapiecentrum bij betrokken is geweest. Dit noemen we "DUPROTON-geaffilieerde studies". Onder Extern staan relevante internationale publicaties waar geen centrum vanuit Nederland bij betrokken is geweest.

Publicaties

Reduction of organ of interest dose in proton therapy for oesophageal cancer through optimized setup robustness settings and online adaptation

Multicentre dosimetry audit in the European randomized phase III study of neoadjuvant chemoradiotherapy using proton versus photon radiotherapy in locally advanced oesophageal cancer

Prediction of pneumonia following neoadjuvant chemoradiotherapy in patients with oesophageal cancer

External validation of a lung cancer-based prediction model for two-year mortality in esophageal cancer patient cohorts.

National indication protocol for proton radiotherapy in esophageal cancer patients in the Netherlands.

Development of a National Indication Protocol for Proton Therapy in Patients With Seminoma Testis to Reduce the Risk on Subsequent Primary Cancers

Selection of patients for proton therapy to reduce risk of second primary lung and breast cancer

Improved organs-of-interest dose reduction potential with intensity modulated proton therapy and breath-hold in mediastinal lymphoma

Feasibility of reduced setup uncertainty in intensity-modulated proton therapy for mediastinal lymphoma

Selection of patients for proton therapy to reduce risk of second primary lung and breast cancer